Archive

You are viewing the "Bill Chappell | NPR" Archives

A healthcare worker administers a dose of a Pfizer-BioNTech Covid-19 vaccine to a child at a pediatrician's office in Bingham Farms, Michigan, U.S., on Wednesday, May 19, 2021.

Pfizer Submits Favorable Initial Data To The FDA On Kids’ COVID-19 Vaccine Trial

By:
Posted on:

WASHINGTON, D.C. (NPR) — Pfizer and BioNTech are another step closer to seeking authorization for young children to receive the COVID-19 coronavirus vaccine, submitting data to the Food and Drug Administration that shows a “robust” antibody response and “favorable” safety outcomes in kids ages 5 to 11 who received the two-dose regimen in clinical trials…. Read More